Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure
Kymberleigh A. Romano(MACOM (United States)), Stanley L. Hazen(Cleveland Clinic), Elisabeth Steinhagen‐Thiessen(Charité - Universitätsmedizin Berlin), Beth Lovano(L-3 Communications (United States)), W.H. Wilson Tang(Cleveland Clinic), Ina Nemet(Cleveland Clinic Lerner College of Medicine), Maradumane L. Mohan(L-3 Communications (United States)), Fredrik Bäckhed(Sahlgrenska University Hospital), Xinmin S. Li(Cleveland Clinic), Prasenjit Prasad Saha(Cleveland Clinic Lerner College of Medicine), Sathyamangla V Naga Prasad(Cleveland Clinic Lerner College of Medicine), Yu Sun(Dalian Municipal Central Hospital), Joseph A. DiDonato(Cleveland Clinic), Arjun Deb(Nanosys (United States)), Maximilian König(Charité - Universitätsmedizin Berlin), Ilja Demuth(Charité - Universitätsmedizin Berlin), Jennifer A. Buffa(Cleveland Clinic), David R. Van Wagoner(Cleveland Clinic), Ulf Landmesser(Deutsches Herzzentrum der Charité), Christopher M. Menge(L-3 Communications (United States)), Lin Li(Cleveland Clinic), Marco Witkowski(Cleveland Clinic), Laurie Castel(MACOM (United States)), Arash Haghikia(German Centre for Cardiovascular Research)
Cited by 150
Related Papers
Obesity alters gut microbial ecology
|Proceedings of the National Academy of Sciences|2005|6.1k
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
|Nature Medicine|2013|4.4k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
|European Heart Journal|2016|3.2k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k